Clinical Trial

Gene Therapy for SLC6A1 Neurodevelopmental Disorder

Name: Gene Therapy for SLC6A1 Neurodevelopmental Disorder — clinical trial record (NCT07173153)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Enrolling by Invitation Phase 1/2

View on ClinicalTrials.gov →

Summary

This is gene therapy study of an AAV9 vector carrying the SLCA1 gene for SLC6A1 neurodevelopmental disorder.

Trial Details

NCT Number	NCT07173153
Lead Sponsor	Emily de los Reyes
Conditions	SLC6A1
Enrollment	1 participants
Start Date	2025-08-25
Primary Completion	2028-08-25 (estimated)
Study Completion	2030-08-25 (estimated)
Updated on ClinicalTrials.gov	2025-09-15